GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 299 filers reported holding GW PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 1.28 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $13,029,000 | -3.5% | 112,897 | -18.6% | 0.05% | -9.3% |
| Q3 2020 | $13,507,000 | -40.5% | 138,745 | -25.0% | 0.05% | -46.0% |
| Q2 2020 | $22,709,000 | -30.1% | 185,045 | -50.1% | 0.10% | -50.0% |
| Q1 2020 | $32,475,000 | -16.2% | 370,845 | 0.0% | 0.20% | -2.9% |
| Q4 2019 | $38,776,000 | -9.1% | 370,845 | 0.0% | 0.21% | -29.0% |
| Q3 2019 | $42,658,000 | -33.3% | 370,845 | 0.0% | 0.29% | -33.2% |
| Q2 2019 | $63,930,000 | -11.5% | 370,845 | -13.4% | 0.43% | -6.1% |
| Q1 2019 | $72,206,000 | +73.1% | 428,345 | 0.0% | 0.46% | +35.1% |
| Q4 2018 | $41,717,000 | -39.1% | 428,345 | +8.0% | 0.34% | -24.2% |
| Q3 2018 | $68,526,000 | +52.6% | 396,700 | +23.3% | 0.45% | +33.8% |
| Q2 2018 | $44,904,000 | +79.7% | 321,800 | +45.1% | 0.34% | +59.0% |
| Q1 2018 | $24,990,000 | -14.7% | 221,800 | 0.0% | 0.21% | -16.5% |
| Q4 2017 | $29,280,000 | +284.7% | 221,800 | +195.7% | 0.25% | +309.7% |
| Q3 2017 | $7,612,000 | +454.0% | 75,000 | +400.0% | 0.06% | +342.9% |
| Q2 2016 | $1,374,000 | +27.0% | 15,000 | 0.0% | 0.01% | +27.3% |
| Q1 2016 | $1,082,000 | -72.3% | 15,000 | -84.1% | 0.01% | -80.0% |
| Q4 2013 | $3,912,000 | – | 94,172 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copernicus Capital Management, LLC | 52,488 | $5,110,000 | 4.87% |
| GREAT POINT PARTNERS LLC | 520,232 | $50,645,000 | 4.56% |
| Integral Health Asset Management, LLC | 65,000 | $6,328,000 | 1.94% |
| CLOUGH CAPITAL PARTNERS L P | 190,716 | $18,566,000 | 1.34% |
| Parkman Healthcare Partners LLC | 50,000 | $4,868,000 | 1.29% |
| ETF MANAGERS GROUP, LLC | 375,344 | $36,540,000 | 1.16% |
| Redwood Investments, LLC | 124,094 | $12,081,000 | 1.02% |
| Eventide Asset Management | 436,000 | $42,445,000 | 0.83% |
| Bellevue Group AG | 562,943 | $54,803,000 | 0.76% |
| ROOSEVELT INVESTMENT GROUP LLC | 95,499 | $9,297,000 | 0.75% |